You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 23, December 17, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  The World in Medicine
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Neurology
 •Multiple Sclerosis/ Demyelinating Disease
 •Genetics
 •Genetic Disorders
 •Immunology
 •Immunologic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Multiple Sclerosis Clue

Joan Stephenson, PhD

JAMA. 2008;300(23):2717.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A team of European scientists has discovered the first genetic variant for multiple sclerosis (MS) that is specifically active in neurons (Aulchenko YS et al. Nat Genet. 10.1038/ng.251 [published online ahead of print November 9, 2008]).

Variants that increase the risk of MS had previously been identified, in genes that affect immune function—not surprising in light of compelling evidence of autoimmunity's role in MS. However, studies also have suggested that neurodegenerative processes play a role in disease progression.

Some of the researchers had found evidence in an earlier study of a genetically isolated Dutch population that linked MS with a variant in KIF1B, a gene that encodes a member of a family of proteins involved in transport of cellular components along axons. The link was confirmed in the current genomewide association study, which involved individuals from the Netherlands, Sweden, and Belgium—2634 with MS and 2930 . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.